Can the shingles vaccine lower dementia risk? What newer U.S. studies show

New U.S. research is prompting a practical question many adults may ask: if the shingles vaccine helps prevent a painful infection, could it also be linked to better brain health later on?

So far, the careful answer is possibly, but not proven. Recent studies found that older adults who received Shingrix were diagnosed with dementia less often than similar adults who did not get the vaccine. That is an association, not proof that the vaccine prevents Alzheimer’s disease or other forms of dementia.

What is already clear is simpler: Shingrix is recommended in the United States to prevent shingles and its complications. The newer dementia findings do not change that basic reason for getting vaccinated.

What Shingrix is already recommended for

CDC recommends Shingrix for adults age 50 and older and for adults 19 and older who have weakened immune systems because of disease or treatment. It is given as a two-dose series. For adults 50 and older with healthy immune systems, CDC says the vaccine is more than 90% effective at preventing shingles and postherpetic neuralgia, the long-lasting nerve pain that can follow shingles.

That matters because shingles is more than a rash. It can cause severe pain, and the risk rises with age. Current CDC guidance is based on preventing shingles and its complications, not on preventing dementia.

What the newer U.S. studies found

In one 2026 study of U.S. Medicare beneficiaries age 65 and older, adults who got the full two-dose recombinant zoster vaccine series had lower rates of new dementia diagnoses than similar adults who did not. The study reported dementia incidence of 10.45 per 1,000 person-years in vaccinated adults versus 15.73 per 1,000 person-years in unvaccinated adults.

A separate U.S. cohort study using Kaiser Permanente Southern California records also found lower dementia risk after two doses of Shingrix. Importantly, that study did more than compare vaccinated people with unvaccinated people. It also compared Shingrix recipients with adults who received Tdap, another routine vaccine. The association became smaller in that comparison but still remained, which suggests the finding may not be explained only by the fact that people who get vaccinated can differ from people who do not.

Public-facing coverage from CIDRAP also highlighted a June 2026 Annals of Internal Medicine study involving more than 500,000 people connected to U.S. skilled nursing facilities. That study reported a lower dementia diagnosis risk for up to four years after recombinant zoster vaccination in a higher-risk population. But that study, like the others, was observational.

Why researchers are still cautious

These studies are promising, but they do not prove cause and effect. Researchers were looking at medical records and claims data, not randomly assigning people to get vaccinated or not. That means hidden differences between groups could still affect the results.

For example, vaccinated adults may be more likely to use preventive care, fill prescriptions, follow up with clinicians, or differ in ways that are hard to fully measure. Dementia diagnosis can also be tricky in real-world records, especially early in the disease.

Researchers have proposed several possible explanations, including lower inflammation after preventing shingles or fewer shingles-related vascular problems. But those are still theories. At this point, no U.S. guideline recommends Shingrix as a dementia-prevention treatment.

What this means for adults 50 and older

If you are already eligible for Shingrix, the new studies may give you one more reason to ask about getting up to date. But they are not a reason to use the vaccine as a stand-alone brain-health strategy, and they are not a substitute for a medical evaluation if memory or thinking problems are already affecting daily life.

The most practical takeaway is that the vaccine already has a strong, proven benefit: it helps prevent shingles and one of its most disabling complications. The dementia signal is interesting and worth following, but it is not settled science.

What about cost and insurance?

For many Medicare enrollees, access is better than it used to be. Medicare.gov says people with Medicare Part D pay nothing for the shingles vaccine. Private insurance often covers it too, but out-of-pocket costs can still vary by plan, provider, and where you get vaccinated. Medicaid coverage can also differ by state and plan.

If cost is a concern, it is reasonable to check with your pharmacy, clinician, or insurance plan before the appointment so you know whether there could be any charges.

When memory changes deserve medical attention

The Alzheimer’s Association says warning signs that should not be brushed off include forgetting recently learned information, asking the same questions over and over, trouble managing bills or following familiar steps, getting lost in familiar places, new problems with words, and changes that interfere with everyday tasks.

If you notice those kinds of changes in yourself or someone else, it is a good idea to schedule a medical evaluation instead of assuming it is normal aging. If confusion comes on suddenly, or happens with trouble speaking, weakness, or other abrupt neurologic symptoms, seek urgent medical help right away.

Bottom line

New U.S. studies suggest that Shingrix may be linked to a lower risk of later dementia diagnoses. But the evidence so far shows an association, not proof of prevention. For now, adults should think of Shingrix as a recommended shingles vaccine that may have an added upside researchers are still trying to confirm.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.